HRP960558B1 - New crystalline modifications of cdch, processes for the preparation thereof and pharmaceutical compositions containing them - Google Patents

New crystalline modifications of cdch, processes for the preparation thereof and pharmaceutical compositions containing them

Info

Publication number
HRP960558B1
HRP960558B1 HR960558A HRP960558A HRP960558B1 HR P960558 B1 HRP960558 B1 HR P960558B1 HR 960558 A HR960558 A HR 960558A HR P960558 A HRP960558 A HR P960558A HR P960558 B1 HRP960558 B1 HR P960558B1
Authority
HR
Croatia
Prior art keywords
cdch
processes
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
HR960558A
Other languages
English (en)
Inventor
Alfons Grunenberg
Patrick Bosche
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7779831&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP960558(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of HRP960558A2 publication Critical patent/HRP960558A2/hr
Publication of HRP960558B1 publication Critical patent/HRP960558B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR960558A 1995-12-12 1996-11-25 New crystalline modifications of cdch, processes for the preparation thereof and pharmaceutical compositions containing them HRP960558B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19546249A DE19546249A1 (de) 1995-12-12 1995-12-12 Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen

Publications (2)

Publication Number Publication Date
HRP960558A2 HRP960558A2 (en) 1998-02-28
HRP960558B1 true HRP960558B1 (en) 2002-04-30

Family

ID=7779831

Family Applications (1)

Application Number Title Priority Date Filing Date
HR960558A HRP960558B1 (en) 1995-12-12 1996-11-25 New crystalline modifications of cdch, processes for the preparation thereof and pharmaceutical compositions containing them

Country Status (42)

Country Link
US (1) US5849752A (ko)
EP (1) EP0780390B1 (ko)
JP (1) JP4104687B2 (ko)
KR (1) KR100525146B1 (ko)
CN (1) CN1061348C (ko)
AR (1) AR005009A1 (ko)
AT (1) ATE221531T1 (ko)
AU (1) AU708006B2 (ko)
BG (1) BG62258B1 (ko)
BR (1) BR9605968A (ko)
CA (1) CA2192418C (ko)
CO (1) CO4480105A1 (ko)
CU (1) CU22774A3 (ko)
CZ (1) CZ288657B6 (ko)
DE (2) DE19546249A1 (ko)
DK (1) DK0780390T3 (ko)
EE (1) EE03474B1 (ko)
ES (1) ES2179910T3 (ko)
HR (1) HRP960558B1 (ko)
HU (1) HU226521B1 (ko)
ID (1) ID22625A (ko)
IL (1) IL119795A (ko)
IN (1) IN185805B (ko)
MA (1) MA24342A1 (ko)
MY (1) MY117492A (ko)
NL (1) NL300109I1 (ko)
NO (1) NO306725B1 (ko)
NZ (1) NZ299905A (ko)
PL (1) PL184885B1 (ko)
PT (1) PT780390E (ko)
RO (1) RO119782B1 (ko)
RU (1) RU2162468C2 (ko)
SA (1) SA96170492B1 (ko)
SG (1) SG47201A1 (ko)
SI (1) SI0780390T1 (ko)
SK (1) SK282805B6 (ko)
SV (1) SV1996000109A (ko)
TR (1) TR199600970A2 (ko)
TW (1) TW411340B (ko)
UA (1) UA35638C2 (ko)
YU (1) YU49485B (ko)
ZA (1) ZA9610405B (ko)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1017392T1 (en) * 1997-09-25 2002-12-31 Bayer Aktiengesellschaft Medicament formulation with a controlled release of an active agent
DE19751948A1 (de) 1997-11-24 1999-05-27 Bayer Ag Verfahren zur Herstellung von 8-Methoxy-Chinoloncarbonsäuren
US6395746B1 (en) 1998-09-30 2002-05-28 Alcon Manufacturing, Ltd. Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6716830B2 (en) 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6509327B1 (en) 1998-09-30 2003-01-21 Alcon Manufacturing, Ltd. Compositions and methods for treating otic, ophthalmic and nasal infections
SI1128831T1 (en) * 1998-11-10 2005-04-30 Bayer Healthcare Ag Pharmaceutical moxifloxacin preparation
DE19854357A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854356A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) * 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
US20060252789A1 (en) * 2002-10-31 2006-11-09 Sujay Biswas Amorphous moxifloxacin hydrochloride
CA2521398C (en) * 2003-04-09 2011-03-22 Dr. Reddy's Laboratories Limited A crystalline form iii of anhydrous moxifloxacin hydrochloride and a process for preparation thereof
EP1651630A1 (en) * 2003-08-05 2006-05-03 Matrix Laboratories Ltd An improved process for the preparation of moxifloxacin hydrochloride
ITMI20032259A1 (it) 2003-11-20 2005-05-21 Chemi Spa Nuovo polimorfo dell'acido 1-ciclopropil-7-(s,s-2,8-diazabciclo-4.3.0-non-8-il)-6-fluoro-1,4-diidro-8-metossi-4-oxo-chinolin carbossilico cloridrato e metodi per la sua preparazione
EP1685130B1 (en) * 2003-11-20 2008-12-10 CHEMI S.p.A. Polymorphs of 1-cyclopropyl-7-([s,s] - 2,8-diazadicyclo [4.3.0] non-8-yl) -6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof
US7491725B2 (en) 2004-02-06 2009-02-17 Bristol-Myers Squibb Company Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
DE102004063347A1 (de) * 2004-12-23 2006-07-13 Stada Arzneimittel Ag Gebrauchsfertige Gemcitabinlösungen und Gemcitabinlösungskonzentrate
WO2007033515A1 (fr) * 2005-09-21 2007-03-29 Shenzhen Tys R & D Co., Ltd. Formulation orale contenant de la moxifloxacine et son procédé de préparation
GB0612422D0 (en) * 2006-06-23 2006-08-02 Generics Uk Ltd Novel hydrate form
US20100204470A1 (en) 2006-06-27 2010-08-12 Sandoz Ag method for salt preparation
ES2303768B1 (es) * 2006-09-08 2009-06-05 Quimica Sintetica, S.A. Nueva forma cristalina de moxifloxacino clorhidrato.
AU2007320997B2 (en) * 2006-11-13 2012-11-08 Cipla Limited Process for the synthesis of moxifloxacin hydrochloride
EP1992626A1 (en) * 2007-05-10 2008-11-19 Sandoz AG Process for the preparation of moxifloxacin hydrochloride
EP2083010A1 (en) * 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof
EP2154137A1 (en) 2008-08-04 2010-02-17 Chemo Ibérica, S.A. Crystalline form of moxifloxacin base
JP5461565B2 (ja) * 2008-10-09 2014-04-02 アブディ イブラヒム イラク サナイ ベ ティカレット アノニム シルケティ 有機溶媒を使用したモキシフロキサシンの湿式造粒法
WO2010052726A1 (en) * 2008-11-06 2010-05-14 Hetero Research Foundation Novel polymorph of moxifloxacin hydrochloride
WO2010066385A1 (de) 2008-12-08 2010-06-17 Ratiopharm Gmbh Kompaktiertes moxifloxacin
WO2010131054A1 (en) 2009-05-15 2010-11-18 Bradford Pharma Limited Redox drug derivatives
WO2011121596A2 (en) * 2010-04-01 2011-10-06 Neuland Laboratories Ltd. Crystal modification of moxifloxacin hydrochloride
BRPI1106900A2 (pt) 2011-12-26 2013-11-05 Ems Sa Composição farmacêutica sólida compreendendo antibótico da familia das quinolonas e processo de sua obtenção
FR2992218B1 (fr) 2012-06-22 2015-01-23 Rivopharm Sa Composition pharmaceutique de chlorhydrate de moxifloxacine et procede de preparation
CN102924449B (zh) * 2012-10-30 2015-08-12 重庆福安药业集团庆余堂制药有限公司 盐酸莫西沙星h晶型及其制备方法和药物组合物
WO2014087292A1 (en) 2012-12-04 2014-06-12 Mankind Research Centre An improved process for the preparation of moxifloxacin hydrochloride
RU2561037C2 (ru) * 2013-02-07 2015-08-20 Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") Антибактериальная фармацевтическая композиция и способ ее получения
MX2015011760A (es) 2013-03-15 2016-06-10 Melinta Therapeutics Inc Metodos para tratar infecciones en pacientes obesos y con sobrepeso usando antibioticos.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
NO871333L (no) * 1986-03-31 1987-10-01 Sankyo Co Kinolin-3-karboksylsyrederivater, fremgangsmaate til fremstilling og anvendelse derav.
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
TW209865B (ko) 1992-01-10 1993-07-21 Bayer Ag
ATE207479T1 (de) * 1992-01-31 2001-11-15 Chugai Pharmaceutical Co Ltd Kristalle von derivaten von chinozon carbonsäure- hydraten
DE4234078A1 (de) 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
NO301165B1 (no) * 1992-12-25 1997-09-22 Daiichi Seiyaku Co Bicykliske aminderivater og antibakterielle midler inneholdende disse
ZA946853B (en) * 1993-09-10 1995-04-24 Daiichi Seiyaku Co Crystals of antimicrobial compound.
DK0676199T3 (da) * 1994-04-07 1999-02-08 Pfizer Anvendelse af trovafloxacin eller derivater deraf til fremstilling af et medikament til behandling af H. pylori-infektione

Also Published As

Publication number Publication date
CZ364696A3 (en) 1997-07-16
ATE221531T1 (de) 2002-08-15
UA35638C2 (uk) 2001-04-16
YU49485B (sh) 2006-08-17
RO119782B1 (ro) 2005-03-30
DK0780390T3 (da) 2002-11-11
HUP9603428A2 (en) 1997-08-28
PL184885B1 (pl) 2003-01-31
CN1160052A (zh) 1997-09-24
SK282805B6 (sk) 2002-12-03
SV1996000109A (es) 1997-10-23
ID22625A (id) 1999-12-02
NO306725B1 (no) 1999-12-13
EP0780390A1 (de) 1997-06-25
EP0780390B1 (de) 2002-07-31
SK159196A3 (en) 1997-10-08
EE9600201A (et) 1997-06-16
ZA9610405B (en) 1997-06-23
SG47201A1 (en) 1998-03-20
SA96170492B1 (ar) 2006-05-23
IL119795A (en) 1998-12-27
IL119795A0 (en) 1997-03-18
YU65096A (sh) 1998-12-23
MY117492A (en) 2004-07-31
CA2192418A1 (en) 1997-06-13
SI0780390T1 (en) 2002-10-31
IN185805B (ko) 2001-05-05
BR9605968A (pt) 1998-08-18
TW411340B (en) 2000-11-11
AR005009A1 (es) 1999-04-07
AU7421696A (en) 1997-06-19
CU22774A3 (es) 2002-07-24
KR970042550A (ko) 1997-07-24
NO965298L (no) 1997-06-13
BG101043A (en) 1998-04-30
NL300109I1 (nl) 2003-02-03
CA2192418C (en) 2001-06-12
BG62258B1 (bg) 1999-06-30
MA24342A1 (fr) 1998-07-01
JP4104687B2 (ja) 2008-06-18
KR100525146B1 (ko) 2006-01-27
HU226521B1 (en) 2009-03-30
NO965298D0 (no) 1996-12-11
AU708006B2 (en) 1999-07-29
HUP9603428A3 (en) 1997-10-28
NZ299905A (en) 1998-09-24
PL317415A1 (en) 1997-06-23
US5849752A (en) 1998-12-15
RU2162468C2 (ru) 2001-01-27
PT780390E (pt) 2002-11-29
EE03474B1 (et) 2001-08-15
DE59609501D1 (de) 2002-09-05
CO4480105A1 (es) 1997-07-09
HRP960558A2 (en) 1998-02-28
MX9606325A (es) 1997-10-31
CZ288657B6 (cs) 2001-08-15
JPH09169757A (ja) 1997-06-30
HU9603428D0 (en) 1997-01-28
TR199600970A2 (tr) 1997-06-21
CN1061348C (zh) 2001-01-31
DE19546249A1 (de) 1997-06-19
ES2179910T3 (es) 2003-02-01

Similar Documents

Publication Publication Date Title
HRP960558B1 (en) New crystalline modifications of cdch, processes for the preparation thereof and pharmaceutical compositions containing them
HUP9603495A3 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation
IL118369A0 (en) Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
HUP9603494A3 (en) Hydroxycarboxamide derivatives, pharmaceutical compositions containing them, process for the preparation thereof
HUP0001607A3 (en) Thienopyrimidine derivatives, pharmaceutical compositions containing them, process for their preparation and use of the compounds
ZA969248B (en) New aminoacid derivatives process for the manufacture thereof and pharmaceutical compositions containing thesse compounds
IL112193A0 (en) Phenylpyrazolopyridine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
EP0811595A4 (en) HYDROCHALCONE DERIVATIVES, COSMETIC COMPOSITIONS CONTAINING THEM AND PROCESSES FOR PREPARING SUCH DERIVATIVES OR COMPOSITIONS
AU6362796A (en) Substituted 4-phenylaminothiazoles, their process for preparation and the pharmaceutical compositions containing them
ZA962916B (en) New arylglycineamide derivatives processes for the manufacture thereof and pharmaceutical compositions containing these compounds
HUP9602635A3 (en) 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them
AU2974189A (en) Pharmaceutical compositions containing lactams, new substituted lactams and processes for the preparation thereof
IL113103A0 (en) Piperidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL117620A0 (en) Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0003053A3 (en) Crystalline forms of 33-epichloro-33-desoxyascomycin, process for their preparation and pharmaceutical compositions containing them
HUP9901485A3 (en) Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use
IL117495A0 (en) Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
HUP9802393A3 (en) Benzothiazolone derivatives, their use, pharmaceutical compositions containing them, process for the preparation thereof and intermediates
IL107358A0 (en) a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
HUP9601680A3 (en) Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds
AU4878997A (en) Novel isoxazol derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the novel compounds
HUP9800631A3 (en) 4-aminotetrahydrobenzisoxazole or -isothiazole derivatives, pharmaceutical compositions containing them and their use for the preparation of pharmaceutical compositions
HUP9801068A3 (en) 1,2,3,4-tetrahydro-2-naphtaleneamine derivatives, process for their preparation, their use, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
PPPP Transfer of rights

Owner name: BAYER HEALTHCARE AG, DE

PPPP Transfer of rights

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE

PNAN Change of the applicant name, address/residence

Owner name: BAYER PHARMA AG, DE

PPPP Transfer of rights

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

ODRP Renewal fee for the maintenance of a patent

Payment date: 20151030

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20161125